Calamos Wealth Management LLC Pfizer Inc Transaction History

Calamos Wealth Management LLC

$1.89 Billion
Q3 2024

A detailed history of Calamos Wealth Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Calamos Wealth Management LLC holds 52,005 shares of PFE stock, worth $1.39 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

52,005

Previous 52,085 0.15%

Holding current value

$1.39 Million

Previous $1.46 Million 3.29%

% of portfolio

0.08%

Previous 0.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$27.7 - $31.39 $2,216 - $2,511	-80 Reduced 0.15%	52,005 $1.51 Million
Q2 2024 Jul 25, 2024	SELL	$25.26 - $29.6 $72,875 - $85,396	-2,885 Reduced 5.25%	52,085 $1.46 Million
Q1 2024 May 08, 2024	BUY	$25.89 - $29.73 $11,909 - $13,675	460 Added 0.84%	54,970 $1.53 Million
Q4 2023 Jan 31, 2024	SELL	$26.13 - $33.94 $255,028 - $331,254	-9,760 Reduced 15.19%	54,510 $1.57 Million
Q3 2023 Oct 25, 2023	SELL	$32.09 - $37.51 $57,601 - $67,330	-1,795 Reduced 2.72%	64,270 $2.13 Million
Q2 2023 Jul 28, 2023	SELL	$36.12 - $41.79 $46,414 - $53,700	-1,285 Reduced 1.91%	66,065 $2.42 Million
Q1 2023 May 03, 2023	SELL	$39.39 - $51.28 $1,181 - $1,538	-30 Reduced 0.04%	67,350 $2.75 Million
Q4 2022 Jan 25, 2023	SELL	$41.75 - $54.5 $25,384 - $33,136	-608 Reduced 0.89%	67,380 $0
Q3 2022 Oct 24, 2022	SELL	$43.76 - $53.42 $115,395 - $140,868	-2,637 Reduced 3.73%	67,988 $2.98 Million
Q2 2022 Aug 01, 2022	BUY	$46.53 - $55.17 $230,602 - $273,422	4,956 Added 7.55%	70,625 $3.7 Million
Q1 2022 May 03, 2022	BUY	$45.75 - $56.69 $14,868 - $18,424	325 Added 0.5%	65,669 $3.4 Million
Q4 2021 Feb 01, 2022	SELL	$41.32 - $61.25 $45,699 - $67,742	-1,106 Reduced 1.66%	65,344 $3.86 Million
Q3 2021 Oct 26, 2021	SELL	$39.25 - $50.42 $93,846 - $120,554	-2,391 Reduced 3.47%	66,450 $2.86 Million
Q2 2021 Jul 22, 2021	BUY	$35.91 - $40.68 $63,417 - $71,840	1,766 Added 2.63%	68,841 $2.7 Million
Q1 2021 Apr 12, 2021	SELL	$33.49 - $37.77 $52,076 - $58,732	-1,555 Reduced 2.27%	67,075 $2.43 Million
Q4 2020 Jan 27, 2021	BUY	$33.47 - $42.56 $1.37 Million - $1.74 Million	40,933 Added 147.79%	68,630 $2.53 Million
Q3 2020 Oct 26, 2020	SELL	$31.75 - $37.25 $153,574 - $180,178	-4,837 Reduced 14.87%	27,697 $1.02 Million
Q2 2020 Jul 27, 2020	SELL	$30.12 - $36.54 $290,115 - $351,953	-9,632 Reduced 22.84%	32,534 $1.06 Million
Q1 2020 Apr 28, 2020	SELL	$27.03 - $38.62 $3.47 Million - $4.95 Million	-128,231 Reduced 75.25%	42,166 $1.38 Million
Q4 2019 Jan 15, 2020	BUY	$32.92 - $37.36 $20,081 - $22,789	610 Added 0.36%	170,397 $6.68 Million
Q3 2019 Oct 21, 2019	BUY	$32.49 - $42.13 $86,423 - $112,065	2,660 Added 1.59%	169,787 $6.1 Million
Q2 2019 Aug 07, 2019	BUY	$36.98 - $41.52 $74,255 - $83,372	2,008 Added 1.22%	167,127 $7.24 Million
Q1 2019 Apr 12, 2019	BUY	$37.5 - $41.2 $1.86 Million - $2.04 Million	49,620 Added 42.96%	165,119 $7.01 Million
Q4 2018 Jan 24, 2019	BUY	$38.47 - $43.86 $143,608 - $163,729	3,733 Added 3.34%	115,499 $5.04 Million
Q3 2018 Oct 22, 2018	BUY	$34.47 - $41.81 $15,442 - $18,730	448 Added 0.4%	111,766 $4.93 Million
Q2 2018 Jul 17, 2018	SELL	$32.98 - $35.16 $97,192 - $103,616	-2,947 Reduced 2.58%	111,318 $4.04 Million
Q1 2018 Apr 13, 2018	BUY	$31.91 - $37.02 $66,021 - $76,594	2,069 Added 1.84%	114,265 $4.06 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $73,604 - $78,096	-2,213 Reduced 1.93%	112,196 $4.06 Million
Q3 2017 Oct 25, 2017	BUY	$31.0 - $34.15 $48,360 - $53,274	1,560 Added 1.38%	114,409 $4.08 Million
Q2 2017 Aug 09, 2017	BUY	N/A	112,849	112,849 $3.79 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Wealth Management LLC with notifications on news.

Account

Calamos Wealth Management LLC Pfizer Inc Transaction History